Yu H - Search Results

1

[Expression and prognostic significance in epithelial ovarian cancer].

Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M. Katsaros D, et al. Among authors: yu h. Minerva Ginecol. 2002 Feb;54(1):15-24. Minerva Ginecol. 2002. PMID: 11828267 Italian.

2

IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.

Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, Diamandis EP, Massobrio M. Katsaros D, et al. Among authors: yu h. Eur J Cancer. 2001 Mar;37(4):478-85. doi: 10.1016/s0959-8049(00)00423-8. Eur J Cancer. 2001. PMID: 11267857

3

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.

Katsaros D, Cho W, Singal R, Fracchioli S, Rigault De La Longrais IA, Arisio R, Massobrio M, Smith M, Zheng W, Glass J, Yu H. Katsaros D, et al. Among authors: yu h. Gynecol Oncol. 2004 Sep;94(3):685-92. doi: 10.1016/j.ygyno.2004.06.018. Gynecol Oncol. 2004. PMID: 15350359

4

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer.

Wiley A, Katsaros D, Fracchioli S, Yu H. Wiley A, et al. Among authors: yu h. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):210-8. doi: 10.1111/j.1525-1438.2006.00299.x. Int J Gynecol Cancer. 2006. PMID: 16445635

5

IGF-II promoter methylation and ovarian cancer prognosis.

Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H. Beeghly AC, et al. Among authors: yu h. J Cancer Res Clin Oncol. 2007 Oct;133(10):713-23. doi: 10.1007/s00432-007-0211-3. Epub 2007 Jun 14. J Cancer Res Clin Oncol. 2007. PMID: 17569086

6

Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma.

Zarghami N, Katsaros D, Yu H, Diamandis EP. Zarghami N, et al. Among authors: yu h. Can J Oncol. 1995 Sep;5(3):401-7. Can J Oncol. 1995. PMID: 8853514

7

Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.

Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H. Beeghly A, et al. Among authors: yu h. Gynecol Oncol. 2006 Feb;100(2):330-7. doi: 10.1016/j.ygyno.2005.08.035. Epub 2005 Sep 29. Gynecol Oncol. 2006. PMID: 16199080

8

Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.

Levesque MA, Katsaros D, Yu H, Giai M, Genta F, Roagna R, Ponzone R, Massobrio M, Sismondi P, Diamandis EP. Levesque MA, et al. Among authors: yu h. Int J Cancer. 1998 Apr 17;79(2):147-52. doi: 10.1002/(sici)1097-0215(19980417)79:2<147::aid-ijc9>3.0.co;2-t. Int J Cancer. 1998. PMID: 9583729

9

Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.

Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP. Levesque MA, et al. Among authors: yu h. Clin Cancer Res. 2000 Aug;6(8):3260-70. Clin Cancer Res. 2000. PMID: 10955812

10

Prostate-specific antigen in serum of women with breast cancer.

Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP. Giai M, et al. Among authors: yu h. Br J Cancer. 1995 Sep;72(3):728-31. doi: 10.1038/bjc.1995.401. Br J Cancer. 1995. PMID: 7545417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,108 results

Search Page

Filters